| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.23 | 2e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.21 | 1e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.24 | 4e-05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.21 | 6e-05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.11 | 0.05 |